sonoma pharmaceuticals, inc., develops and produces stabilized hypochlorous acid (hocl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the united states and internationally

Sonoma Pharmaceuticals, Inc. Common Stock

Sold all SNOA

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Chase Garan

New position in SNOA

Swapnil Patel

Mike Pelech

Sold 10% of SNOA

Sold 11% of SNOA

Sold 18% of SNOA

Bought 56% more SNOA

Bought 16% more SNOA

Sold short 114% more SNOA

Riley Wong

Bought to close 53% SNOA

Sold short SNOA

Sold 33% of SNOA

Sold 50% of SNOA

Sold 25% of SNOA